Massachusetts General Hospital Sleep Disorders Clinical Research Program

We want to see whether an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type 2 diabetes. No travel to MGH is necessary: all study visits can occur virtually. Three blood draws are required, which can be performed at a local site.

Those who are interested in this research should email [email protected] or visit the following website:

https://rally.partners.org/study/insomnia_type2diabetes.

Study for Adults with Type 2 Diabetes and Difficulty Sleeping at Night This 12-week study requires 4 visits and is investigating the use of an FDA-approved sleeping medication to improve sleep in people who have type 2 diabetes. We are investigating whether improved sleep might improve type 2 diabetes.

We are dedicated to clinical research on sleep disorders, including insomnia in type 2 diabetics, restless legs syndrome, and sleep-related eating disorder. Visit our page to learn more about our studies.

https://www.massgeneral.org/psychiatry/research/sleep-disorders-clinical-research-program

Sleep Disorders Clinical Research Program The Sleep Disorders Clinical Research Program at Mass General is dedicated to clinical and investigative efforts in sleep disorders, including restless legs syndrome, insomnia and sleep-related eating disorder.